Dose-Response Relationship, Immunologic
Showing 1 - 25 of >10,000
Glucose Tolerance Impaired Trial (20% fat meal, 40% fat meal, 60% fat meal)
Not yet recruiting
- Glucose Tolerance Impaired
- 20% fat meal
- +3 more
- (no location specified)
Jun 14, 2023
Mild Cognitive Impairment Trial in Tucson (Transcranial Magnetic Stimulation, Transcranial Magnetic Stimulation (Low Intensity))
Not yet recruiting
- Mild Cognitive Impairment
- Transcranial Magnetic Stimulation
- Transcranial Magnetic Stimulation (Low Intensity)
-
Tucson, ArizonaBioscience Research Laboratory
Aug 22, 2022
HIV, Human Immunodeficiency Virus Trial in Salt Lake City (Euphorbia kansui extract powder prepared as tea)
Suspended
- HIV
- Human Immunodeficiency Virus
- Euphorbia kansui extract powder prepared as tea
-
Salt Lake City, UtahUniversity of Utah
Mar 22, 2022
Articular Cartilage Degeneration Trial in Basel (walking stress test)
Recruiting
- Articular Cartilage Degeneration
- walking stress test
-
Basel, SwitzerlandDepartment of Orthopaedics and Traumatology, University Hospital
Mar 2, 2022
NSCLC Trial in Rockville (Crizotinib - Usual, Crizotinib - Study)
Not yet recruiting
- Non-Small Cell Lung Cancer
- Crizotinib - Usual
- Crizotinib - Study
-
Rockville, MarylandMedicine Invention Design, Inc. - IORG0007849
Oct 5, 2023
Treatment Resistant Depression Trial in Stanford (Active TBS-DLPFC, Sham TBS-DLPFC)
Recruiting
- Treatment Resistant Depression
- Active TBS-DLPFC
- Sham TBS-DLPFC
-
Stanford, CaliforniaDepartment of Psychiatry and Behavioral Sciences, Stanford Schoo
May 5, 2022
Hemophilia A With Inhibitor, Hemophilia B With Inhibitor Trial in Teheran (Eptacog alfa, activated)
Recruiting
- Hemophilia A With Inhibitor
- Hemophilia B With Inhibitor
- Eptacog alfa, activated
-
Teheran, Iran, Islamic Republic ofComprehensive Hemophilia Care Center
Feb 14, 2022
Fertilization Trial (corifollitropin alfa, Follitropin beta injection)
Completed
- Fertilization
- corifollitropin alfa
- Follitropin beta injection
- (no location specified)
Feb 1, 2022
Healthy Volunteers Trial in Paris (ILT101, Placebo)
Completed
- Healthy Volunteers
- ILT101
- Placebo
-
Paris, FranceClinical Investigation Center Paris Est Hôpital Universitaire Pi
Dec 10, 2021
Major Depression in Remission Trial in Ghent (Cognitive control training)
Recruiting
- Major Depression in Remission
- Cognitive control training
-
Ghent, Oost-Vlaanderen, Belgium
- +1 more
Mar 10, 2022
Tuberculosis, Pulmonary, Other Specified Pulmonary Tuberculosis Trial in Cape Town, Mbeya, Mwanza (BTZ-043, Bedaquiline,
Not yet recruiting
- Tuberculosis, Pulmonary
- Other Specified Pulmonary Tuberculosis
- BTZ-043
- +3 more
-
Cape Town, South Africa
- +3 more
Jun 22, 2023
Infections and Infestations, Pulmonary Tuberculosis Trial in South Africa, Tanzania (Delpazolid, Bedaquiline, Delamanid,
Active, not recruiting
- Infections and Infestations
- Pulmonary Tuberculosis
- Delpazolid
- Bedaquiline, Delamanid, Moxifloxacin
-
Tembisa, Gauteng, South Africa
- +4 more
Sep 13, 2022
Psychotic Disorders, Anxiety, Complementary Therapies Trial in Tainan (multisensory stimulation therapy)
Completed
- Psychotic Disorders
- +3 more
- multisensory stimulation therapy
-
Tainan, TaiwanMei-Feng, Lin
Aug 12, 2021
Dose Response Relationship, Drug Trial in Winston-Salem (F-18 FDG PET)
Terminated
- Dose Response Relationship, Drug
- F-18 FDG PET
-
Winston-Salem, North CarolinaWake Forest Baptist Health
Mar 9, 2022
Mitochondrial Function, Glucose Intolerance Trial in Stockholm (Exercise)
Unknown status
- Mitochondrial Function
- Glucose Intolerance
- Exercise
-
Stockholm, SwedenThe Swedish School of Sport and Health Sciences (GIH)
Feb 10, 2021
Advanced Solid Tumor Trial in Portland (HS-110 (viagenpumatucel-L), HS-130)
Active, not recruiting
- Advanced Solid Tumor
- HS-110 (viagenpumatucel-L)
- HS-130
-
Portland, OregonProvidence Portland Medical Center
Feb 2, 2022
Onchocerciasis Trial in Hohoe (emodepside, matching of emodepside, ivermectin)
Recruiting
- Onchocerciasis
- emodepside
- +3 more
-
Hohoe, Volta Region, GhanaUniversity of Health and Allied Services School of Public Health
Dec 17, 2021
Metastatic Renal Cell Cancer, Malignant Melanoma, Metastatic Trial in Meldola (FC) (Boost of radiotherapy + high dose IL-2
Recruiting
- Metastatic Renal Cell Cancer
- Malignant Melanoma, Metastatic
- Boost of radiotherapy + high dose IL-2 treatment
-
Meldola (FC), FC, ItalyUO Oncologia Medica, IRCCS IRST
Feb 25, 2021
Pediatric Adenotonsillectomy, Post Operative Analgesia Trial in Houston (Dexmedetomidine 0.75 mcg/kg, Morphine 50 mcg/kg,
Completed
- Pediatric Adenotonsillectomy
- Post Operative Analgesia
- Dexmedetomidine 0.75 mcg/kg
- +3 more
-
Houston, TexasTexas Children's Hospital, Baylor College of Medicine
Jul 23, 2021
HIV, HIV Seronegativity Trial in United States (ALVAC(2)120(B,MN)GNP (vCP1452))
Completed
- HIV Infections
- HIV Seronegativity
- ALVAC(2)120(B,MN)GNP (vCP1452)
-
Birmingham, Alabama
- +12 more
Oct 13, 2021
Thermogenesis by Different-dosage Mustard Flour Footbaths Trial in Filderstadt (3-g mustard footbath, 6-g mustard footbath, 12-g
Completed
- Thermogenesis by Different-dosage Mustard Flour Footbaths
- 3-g mustard footbath
- +3 more
-
Filderstadt, Baden-Württemberg, GermanyArcim Institute
Sep 18, 2020
Giant Cell Glioblastoma, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Rochester (Laboratory Biomarker Analysis,
Active, not recruiting
- Giant Cell Glioblastoma
- +2 more
- Laboratory Biomarker Analysis
- Malignant Glioma Tumor Lysate-Pulsed Autologous Dendritic Cell Vaccine
-
Rochester, MinnesotaMayo Clinic
Jan 4, 2023
Critically Ill, Septic Shock Trial in Australia (Fludrocortisone Acetate, Standard Therapy)
Recruiting
- Critically Ill
- Septic Shock
- Fludrocortisone Acetate
- Standard Therapy
-
Sydney, New South Wales, Australia
- +8 more
Mar 29, 2021
Infertility Trial in Tokyo (FE 999049, follitropin beta)
Completed
- Infertility
- FE 999049
- follitropin beta
-
Tokyo, JapanInvestigational site (there may be other sites in this country)
Dec 11, 2020